Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06863168 · ClinicalTrials.gov registry record · NA

Cigarillo Public Education Messaging for Black Young Adults

A NA study of Cigarillo Smoking, sponsored by Drexel University.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
2
Study locations

NCT06863168 is a NA study of Cigarillo Smoking that is actively recruiting participants, run by Drexel University. The registered enrollment target is 360 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06863168, a NA study of Cigarillo Smoking, is actively recruiting participants, sponsored by Drexel University.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
2
Study locations

Study Summary

This is a 3-arm randomized controlled trial to examine the effects of cigarillo public education messages among Black young adults who are at-risk for established cigarillo smoking. The primary outcomes are cigarillo harm perceptions, outcome expectancies, and use intentions at 3-month follow-up. Exploratory outcomes are use behaviors (cigarillo smoking initiation and use behaviors) measured at 3-month follow-up. These outcomes will also be measured at 1-month follow-up time point.

Conditions Studied

Interventions

  • BEHAVIORAL Cigarillo Health Harm and Nicotine Addiction Messaging
  • BEHAVIORAL Cigarillo Health Harm and Nicotine Addiction Messaging Contextualized to Outcome Expectancies

Study Locations (2)

Pennsylvania

  • Drexel University - Philadelphia
  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2025-04-17
Est. Completion 2026-08-31
Phase NA

Sponsor

Drexel University

92 total trials

What the Registry Record Tells You About NCT06863168

The ClinicalTrials.gov registry entry for NCT06863168 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cigarillo Smoking appearing as the primary indexed condition, and to 2 interventions - of which Cigarillo Health Harm and Nicotine Addiction Messaging is the first listed.

NCT06863168 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06863168 about?

NCT06863168 is a clinical study titled "Cigarillo Public Education Messaging for Black Young Adults". This is a 3-arm randomized controlled trial to examine the effects of cigarillo public education messages among Black young adults who are at-risk for established cigarillo smoking. The primary outcomes are cigarillo harm perceptions, outcome expectancies, and use intentions at 3-month follow-up. Ex...

What is the current status of trial NCT06863168?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-04-17. Estimated completion is 2026-08-31.

What conditions does trial NCT06863168 study?

This clinical trial studies the following conditions: Cigarillo Smoking.

What interventions are being tested in trial NCT06863168?

The interventions under investigation include: Cigarillo Health Harm and Nicotine Addiction Messaging (BEHAVIORAL), Cigarillo Health Harm and Nicotine Addiction Messaging Contextualized to Outcome Expectancies (BEHAVIORAL).

Who is sponsoring clinical trial NCT06863168?

This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06863168 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.